Skip to main content
ConductScienceScienceDex

Alison B Edelman

NIH Rank #17227
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7566925Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Obstetrics & Gynecology

NIH Funding · FY2025

Linked Award Amount
$962.6K
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#17,227
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Alison B Edelman. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Alison B Edelman as a PI. Multi-PI records show the full award amount for context.

  • 5R01HD105866-04R01
    Pharmacogenomics of an ovulation modulator and the impact on delay of ovulation
    Oregon Health & Science University
    $787.9K
    award amount
  • 75N94020D00016-0-759402500001-1N01
    NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK), PHARMACODYNAMIC (PD) EFFECTS, SAFETY, AND CONTRACEPTIVE EFFICACY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-A
    Oregon Health & Science University
    $97.8K
    award amount
  • 75N94020D00016-P00002-759402300001-1N01
    NICHD:R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL (NON-SEVER
    Oregon Health & Science University
    $70.4K
    award amount
  • 75N94020D00016-0-759402500002-1N01
    NICHD:R&D:CENTRAL LABORATORY FOR A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION:NON-SEVERABLE
    Oregon Health & Science University
    $6.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Alison B Edelman as a PI.

FY2025 award administered by Oregon Health & Science University (OR).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Oregon Health & Science University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Alison B Edelman.

Jon D Hennebold
Oregon Health & Science University
3
shared awards

Explore further

Find collaborators for Alison B Edelman

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →